What We're Reading: Page 312
Industry reads hand-picked by our editors
Mar 02, 2017
-
Kaiser Health News
Patient advocacy groups rake In donations from pharma
-
MIT Technology Review
Amyloid-busting drugs for Alzheimer’s keep failing, but so does everything else
-
Philly.com
Teamsters go after drug wholesaler AmerisourceBergen after opioid crisis hits their homes
-
Fortune
Why Trump’s emotional plea for fast drug approvals will split the pharma industry apart
Mar 01, 2017
Feb 28, 2017
-
The New York Times
How to fight a soaring drug price: Innovate
-
Financial Times
Small patient groups hinder progress of clinical trials
-
Los Angeles Times
Are pharmaceutical companies gouging taxpayers? Lawmakers need to find out
-
Fortune
These were big pharma’s biggest winners and losers in 2016
Feb 27, 2017
Feb 24, 2017
-
Bloomberg
Sworn to secrecy, drugstores stay silent as customers overpay
-
Reuters
Advent raises bid in three-way tussle for Stada
-
The Washington Post
Rise in mumps outbreaks prompts U.S. officials to weigh third vaccine dose
-
Forbes
This company with anti-aging drug is secretly preparing for Trump's new FDA
Feb 23, 2017
-
MIT Technology Review
How did gene therapy go from experimental disasters to wondrous cures?
-
ProPublica
Big pharma quietly enlists leading professors to justify $1,000-per-day drugs
-
Bloomberg
China widens drug insurance coverage, boosting pharma stocks
-
Medical Marketing & Media
Why pharma refuses to see value in 'influence'
-
Harvard Business Review
The Edison of medicine
Feb 22, 2017
-
Boston Business Journal
Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A
-
USA Today
New patient group focuses on drug prices amid bipartisan concern
-
The Hill
Hopes rise for law to expand access to experimental drugs
-
The Atlantic
Is the leading theory about Alzheimer's wrong?
Previous
